Neurocognitive testing
Neurocognitive testing is a behavioral intervention with 20 clinical trials. Currently 8 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
90.0%
9 of 10 finished
10.0%
1 ended early
8
trials recruiting
20
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Measuring and Mapping Cognitive Decline After Brain Radiosurgery
Genetic Studies of Early-onset Dementia
The CDAC Study - Cerebral Dysfunction After Coronary Revascularization
Validation of the Modified Cognitive Assessment Scale (MoCA Blind) for the Diagnosis of Postoperative Neurocognitive Disorders in Patients With Corneal Pathology in Russia.
Biomarker Exploration in Aging, Cognition and Neurodegeneration
Clinical Trials (20)
Measuring and Mapping Cognitive Decline After Brain Radiosurgery
Genetic Studies of Early-onset Dementia
The CDAC Study - Cerebral Dysfunction After Coronary Revascularization
Validation of the Modified Cognitive Assessment Scale (MoCA Blind) for the Diagnosis of Postoperative Neurocognitive Disorders in Patients With Corneal Pathology in Russia.
Biomarker Exploration in Aging, Cognition and Neurodegeneration
A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis
Cognitive Biomarkers in Pediatric Brain Tumor Patients
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
Long Term Follow up of Children Enrolled in the REDvent Study
Neurocognitive Dysfunction After Anesthesia in Patients With Recent Concussion
Cerebral Blood Flow and Childhood Obstructive Sleep Apnea
Neurocognitive Outcomes and Quality of Life in Adults With Maple Syrup Urine Disease (MSUD)
Gilenya's Impact on Cognitive Function and Thalamic Volumes
Cognitive Testing Online in Parkinson's Disease
Neurocognitive Function After Regional and General Anesthesia (245_14 B)
Prognostic Factors Associated With Postoperative Cognitive Dysfunction After Surgery
Inflammatory Cytokines in Symptom Production in Multiple Myeloma
The Effect of Obstructive Sleep Apnea on Medical Outcomes After Gastric Bypass Surgery
Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
All 20 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 20